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Pathogenic Leptospira sp. are spirochetal bacteria responsible for leptospirosis, an 
emerging worldwide zoonosis. These spirochetes are very successful pathogens that 
infect a wide range of hosts such as fish, reptiles, birds, marsupials, and mammals. 
Transmission occurs when chronically infected animals excrete live bacteria in their urine, 
contaminating the environment. Leptospira sp. enter their hosts through damaged skin 
and mucosa. Chronically infected rats and mice are asymptomatic and are considered 
as important reservoirs of the disease. Infected humans may develop either a flu-like, 
usually mild illness with or without chronic asymptotic renal colonization, or a severe acute 
disease with kidney, liver, and heart failure, potentially leading to death. Leptospirosis is 
an economic burden on society due to health-care costs related to elevated morbidity 
of humans and loss of animals of agricultural interest. There are no effective vaccines 
against leptospirosis. Leptospira sp. are difficult to genetically manipulate which delays 
the pace of research progress. In this review, we discuss in an historical perspective how 
animal models have contributed to further our knowledge of leptospirosis. Hamsters, 
guinea pigs, and gerbils have been instrumental to study the pathophysiology of acute 
lethal leptospirosis and the Leptospira sp. genes involved in virulence. Chronic renal col-
onization has been mostly studied using experimentally infected rats. A special emphasis 
will be placed on mouse models, long thought to be irrelevant since they survive lethal 
infection. However, mice have recently been shown to be good models of sublethal 
infection leading to chronic colonization. Furthermore, congenic and transgenic mice 
have proven essential to study how innate immune cells interact with the pathogen and 
to understand the role of the toll-like receptor 4, which is important to control Leptospira 
sp. load and disease. The use of inbred and transgenic mouse models opens up the 
field to the comprehensive study of immune responses to Leptospira sp. infection and 
subsequent pathophysiology of inflammation. It also allows for testing of drugs and 
vaccines in a biological system that can avail of a wealth of molecular tools that enable 
understanding of the mechanisms of action of protective vaccines.
Keywords: Leptospira interrogans, leptospirosis, animal models, hamsters, mouse models, virulence factors, 
TLR4, TLR2
Abbreviations: sp., species; ko, knockout; TLR, toll-like receptor; DAF-1, decay-accelerating factor 1; LPS, lipopolysaccharide; 
NLR, nod-like receptor; PBMC, peripheral blood mononuclear cell; BMM, bone marrow derived macrophages; Ig, immuno-
globulin; LRR, leucine rich repeat; Na/K-ATPase, potassium pump; GLP, glycolipoprotein; IL, interleukin; NO, nitric oxide.
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iNTRODUCTiON
The most important factor in the development of animal models 
of leptospirosis is that experimental infection closely recapitu-
lates natural disease in humans. Only then, these tools can be 
used in fundamental research of Leptospira sp. pathogenesis 
and disease, host–pathogen interactions leading to eradication 
or persistence of Leptospira sp., characterization of pathogen 
associated virulence factors, immune responses to infection 
and subsequent pathophysiology of inflammation. Under the 
realm of applied research, these models can be used to test 
vaccines to prevent infection or disease progression and to 
test therapeutics for cure or to mitigate signs and symptoms of 
the illness. Given the limited availability of properly validated 
biological samples from human leptospirosis patients, animal 
models also provide a source of material (especially urine) 
than can be used to develop proof-of-principle versions of new 
diagnostic assays.
We start the review by defining the enzootic cycle of patho-
genic Leptospira sp. and the clinical presentation of the disease 
in human patients to frame how animal models that address 
distinct components of the cycle contribute to the understanding 
of how reservoir hosts contaminate the environment and enable 
transmission of pathogenic Leptospira sp. to humans and how we 
can use these animals to better understand disease pathogenesis. 
We describe the animal models used to study the forms of lethal, 
sublethal and chronic leptospirosis with an emphasis on mouse 
models.
The mouse is a versatile animal model to study Leptospira sp. 
infection because we can avail of a vast number of reagents and 
genetic backgrounds tailored to providing answers to specific 
questions.
The enzootic Cycle of Pathogenic 
Leptospira sp.
Leptospirosis is an emerging zoonotic disease with a worldwide 
distribution caused by infection with any of the several pathogenic 
serovars of Leptospira sp. The disease affects virtually all verte-
brates and has a broad range of clinical signs and symptoms, from 
mild, subclinical infection to multiple-organ failure and death. 
Leptospira sp. penetrate abraded skin or mucous membranes, 
enter the bloodstream, and disseminate throughout the body. 
The pathogens are easily maintained in sylvatic and domestic 
environments mostly by transmission through rodent species. 
In these reservoirs, infection produces chronic, asymptomatic 
carriage. Some pathogenic Leptospira sp. such as Canicola and 
Hardjobovis are maintained in non-rodent mammal reservoirs. 
Leptospira sp. can then infect livestock and domestic and wild 
animals and cause a range of disease manifestations and carrier 
states. Maintenance of Leptospira sp. in these populations is due 
to their continued exposure to animal reservoirs or to transmis-
sion within animal herds. Accidental hosts like humans can be 
infected by direct contact with reservoir animals or by exposure 
to environmental surface water or soil that is contaminated with 
their urine (1).
Clinical Presentation of the  
Disease in Human Populations
Human leptospirosis ranges in severity from a self-limited febrile 
illness to a fulminant life-threatening illness, also called Weil’s 
disease. When illness occurs, a broad array of organ systems 
may be involved, reflecting the systemic nature of the infec-
tion. As a result, the signs and symptoms of leptospirosis are 
frequently mistaken for other causes of acute febrile syndrome 
(2). A recent systematic review of published cases estimated that 
leptospirosis causes ~1 million cases a year resulting in ~6% 
death rate (3).
Most leptospirosis cases are mild and resolve spontaneously 
(>90%). It typically presents as a biphasic disease, with an initial 
acute illness lasting about 1 week characterized by fever, myal-
gia, and headache that may be confounded with other entities 
such as influenza and dengue fever. In this phase, Leptospira 
sp. are found in blood or in the cerebrospinal fluid. The second 
phase is characterized by the presence of Leptospira sp. in urine 
and the immune response to Leptospira sp. is detectable by 
traditional serological methods. A low percentage of patients 
(<10%) progress to multisystem organ failure and have wide-
spread hematogenous dissemination of pathogens resulting in 
non-oliguric (high-output) renal dysfunction or oliguric renal 
failure (2, 4). Hemorrhagic complications are common and are 
associated with coagulation abnormalities. Severe pulmonary 
hemorrhage syndrome due to extensive alveolar bleeding has a 
fatality rate of >50% (2).
If we consider the clinical outcomes in human populations 
described above, we can group leptospirosis as sublethal and 
lethal infections. Given the most recent numbers (3) on mortal-
ity rates in humans afflicted with leptospirosis, it is reasonable to 
expect that >90% of people go on to develop sublethal cases of 
the disease. In lethal forms of the disease, either the kidney or 
the lung are the affected organs. In addition, patients may also 
present altered mental status due to neuroleptospirosis (5, 6), and 
liver and other organs may also be involved. Although leptospiro-
sis is primarily a zoonosis, with humans considered as accidental 
hosts, it is worth noting that transient Leptospira sp. shedding does 
occur during human infection and human-to-human infection, 
although extremely rare, has been reported (2, 7, 8). Moreover, 
chronic asymptomatic leptospirosis has recently been shown in a 
Peruvian population (9), suggesting that the renal colonization is 
not a peculiarity of some animal carrier but rather it may follow 
severe acute leptospirosis. Thus, there is a wealth of information 
to be learned from sublethal and/or chronic models of Leptospira 
sp. infection.
PHYSiOPATHOLOGY OF  
ANiMAL LePTOSPiROSiS
In this part, we discuss in an historical perspective the use of 
animal models of leptospirosis to better understand the physi-
opathology of the disease, with an emphasis on the mouse model 
that has been largely overlooked.
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Historic Perspective on the Use  
of Animal Models of Leptospirosis
The first animal model of acute Leptospira sp. infection and dis-
ease was reported by Inada and colleagues in 1916. They injected 
blood from a patient with Weil’s disease into monkey, rabbit, rat, 
and guinea pig and observed that 7 days post-infection only the 
guinea pig developed signs and symptoms consistent with Weil’s 
disease. They followed up with microscopic examination of the 
liver and detected a bacterium morphologically identical to the 
spirochete they observed in specimens of blood, intestinal walls, 
and adrenal glands obtained from patients who succumbed to the 
disease. They concluded that this spirochete was the pathogenic 
cause of Weil’s disease and named it Spirochaeta icterohaemor-
rhagiae (10).
In the mid-twentieth century, it was reported that golden 
Syrian hamsters were particularly susceptible to Leptospira sp. 
infection (11). Guinea pigs, golden hamsters, and dogs were 
then used for laboratory studies of pathogenic Leptospira sp. 
infection (12–15). Over the same period, it was also shown that 
young white mice were extremely susceptible to infection with 
Leptospira interrogans serovar Icterohaemorrhagiae (16) and 
that different strains of mice varied greatly in susceptibility to 
this organism (17). Others reported that mice were susceptible 
to some of the Leptospira sp. serotypes isolated in Northern 
Australia and that survivors became permanent renal carriers 
(18). In 1963, a lack of availability of golden Syrian hamsters 
in Australia led Spradbrow to establish a model of Leptospira 
sp. infection in mice (15–20 g, ~6 weeks old), which produced 
acute disease with over 50% of mortality and chronic persistent 
renal infections in the surviving animals. To address the need for 
complete cure of carriers of chronic renal infections, Spradbrow 
used this model to study the effectiveness of antibiotic treat-
ments in clearance of Leptospira sp. from urine and kidney 
and found that streptomycin was the only antibiotic of which 
a single administration regularly cured chronic renal infections 
(19). Interestingly, as recently as 2001, streptomycin was found 
to be the most effective anti-Leptospira sp. antibiotic in patients 
diagnosed with Weil’s disease (20).
Although guinea pigs and golden hamsters were the animals 
most commonly used in laboratory studies of Leptospira sp. infec-
tions in the mid-twentieth century, it was also recognized that 
both species are less convenient to handle than mice, which are 
the ideal laboratory animal. Fast forward 50 years and the same 
questions are debated today worldwide. For example, in the USA, 
the Animal Welfare Act (AWA) (7 U.S.C. § 2131) is the federal law 
that regulates the care and use of animals in research. The AWA 
provides protections for certain species (such as hamsters, guinea 
pigs, dogs, and non-human primates) while excluding others such 
as mice (Mus sp.) and rats (Rattus sp.) bred for research. The fact 
that guinea pigs and hamsters are covered under AWA protected 
species leads to onerous regulation (housing, medical records, 
transportation) and to United States Department of Agriculture 
official yearly inspections, which in turn results in a considerably 
lower use of these animals in US laboratories (5–10% use of all 
protected species). Cumbersome regulations provide the global 
research community with an opportunity to develop additional 
mouse or rat models of research for leptospirosis.
Lethal Leptospirosis in Hamsters  
and Guinea Pigs
Throughout the last quarter of the twentieth century, hamsters have 
been used as the primary model for acute leptospirosis. The route 
of infection is via intraperitoneal injection, usually with Leptospira 
sp. resuspended in EMJH medium. Young hamsters (4 weeks old) 
infected with a broad range of pathogenic serovars of Leptospira 
sp. develop fulminant, disseminated infection, which reproduces 
the severe form of human leptospirosis with the presence of 
Leptospira sp. in the tissues, destruction of hepatocyte junctions 
that leads to jaundice, leukocytosis, hemorrhage, endothelial 
alteration, thrombotic glomerulopathy, and interstitial nephritis 
(21–23). Hamsters are desert animals traditionally not exposed 
to the humid conditions that mediate transmission of Leptospira 
sp. Possibly for that reason, hamsters are exquisitely sensitive to 
leptospirosis since one single organism is able to cause disease 
(23). The severe leptospirosis induced by pathogenic Leptospira 
sp. in hamsters is associated with enhanced expression of pro-
inflammatory cytokines and mediators by peripheral blood cells, 
such as IL-10, IL-1α, TNF-α, and the cyclo-oxygenase 2 (24). 
Upon infection with L. interrogans serovar Icterohaemorrhagiae 
strain Verdun, mRNA levels of these immunomodulators have 
been found to be higher in hamsters that will not survive the 
infection compared to survivors (25). Also, the intensity of the 
pro-inflammatory response varies according to the strain used, as 
do the bacterial loads in organs. Hence, infection with the highly 
virulent (V) serovar Manilae generates higher levels of cytokine 
transcripts in lungs and liver compared to the infection with L. 
interrogans Hebdomadis (26). These data suggest that the uncon-
trolled cytokine production found in hamsters upon infection 
with pathogenic Leptospira sp. may mimic the adverse cytokine 
storm described in sepsis.
Common applications of the hamster model of leptospirosis 
include determination of strain infectivity, routes of infection 
(27), restoring virulence to culture-attenuated strains, assess-
ing usefulness of potential vaccines or diagnostic antigens, and 
examining pathology of kidney (23).
Severe pulmonary leptospirosis has been studied using the 
guinea pig model (28) as it replicates the pulmonary hemorrhage 
and respiratory failure seen in humans. Studies of this model 
revealed thrombocytopenia, extensive hemorrhage of the lungs, 
absence of intravascular coagulation, and extensive deposition of 
immunoglobulin and complement along the alveolar basement 
membrane, which suggested that an immune process may be 
involved in the etiology of fatal pulmonary hemorrhage in lep-
tospirosis (28, 29). The same pathology was replicated in dogs, 
which could also be used as a natural disease model for human 
leptospirosis (30).
Mouse Models of Leptospirosis
Rats and some strains of mice (31) are generally unsuitable 
hosts for acute lethal leptospirosis because they develop severe 
signs of disease only within a short window of time after birth, 
before 3–4 weeks, but afterward no longer succumb to infection 
(32). This suggests that a mature immune system achieved by 
5 weeks of age in mice (33) is required to control leptospirosis to 
ensure survival. However, a number of inbred wild-type (WT), 
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immunosuppressed, or transgenic mice have been used as models 
of lethal, sublethal and chronic leptospirosis. A summary of mice 
as animal models to study leptospirosis is provided below and in 
Table 1.
Mouse Models of Lethal Leptospirosis
As the use of inbred strains of mice became ubiquitous in labora-
tory testing, adult BALB/c mice were infected in the mid-70s 
with several genospecies of pathogenic Leptospira sp. These 
mice presented with non-lethal dissemination of the bacteria in 
blood and in tissues, and thus, this mouse strain was associated 
with resistance to acute Leptospira sp. infection (38). However, 
there are a number of examples of lethal infection of several 
strains of mice such as infection of adult C57BL/6 mice with 108 
L. interrogans serovar Manilae (38), infection of immunosup-
pressed BALB/c mice with L. interrogans serovar Pomona (43). 
Adult C57BL/6 mice deficient for toll-like receptor 4 (TLR4) 
or myeloid differentiation factor 88 (MyD88) (44), μMT mice 
devoid of B cells (44) as well as C57BL/6 mice deficient for 
the decay-accelerating factor (DAF)-1ko (37), were shown to 
die after infection with L. interrogans serovar Copenhageni. 
Furthermore, infection of 4-week old C3H–HeJ mice with L. 
interrogans serovar Icterohaemorrhagiae led to lethality with 
pulmonary hemorrhage (39). C3H/SCID mice devoid of B and 
T cells were also sensitive and died from the infection with L. 
interrogans serovar Copenhageni, without lung hemorrhage 
(40). Those murine models presenting targeted deficiencies 
in immune system receptors have been instrumental in the 
discovery of many key factors required to control Leptospira sp. 
in mammalian hosts and are discussed in part 2 of this review. 
Lethal infection of mice is observed using high doses of inocu-
lum of Leptospira sp. (usually 106–108), whereas in the hamster 
model, lethal doses of inoculum of Leptospira sp. range between 
102 and 103. However, infection of 5-week-old hamsters with 
doses ranging from 102 to 106 led to a progressive increase in ani-
mal survival with a 50% survival rate in hamsters infected with 
106 Leptospira kirschneri (45), which constitutes an interesting 
paradox. Although Leptospira sp. numbers such as 102–5 × 103 
were previously quantified in urban slum water gutters in the 
Peruvian Amazon region of Iquitos (9), the minimum or median 
Leptospira sp. infectious dose in humans is unknown.
Mouse Models of Sublethal Leptospirosis
Lethal outcome inconsistencies in the former studies raised 
questions regarding the potential usefulness of mice in under-
standing pathogenesis and clinical disease progression. In the 
last decade, there has been a surge in the number of studies 
investigating outcomes of experimental leptospirosis among 
different strains of mice such as A, CBA, BALB/c, C57BL/6, 
and C3H–HeJ mice, all showing sublethal infections after 
intraperitoneal inoculation (34–36, 41, 46) (Table 1). Infection 
of mice strains A, CBA, and C57BL/6 with L. interrogans serovar 
Copenhageni strain Cop led to dissemination of Leptospira sp. to 
the kidneys one month post-infection and to nephritis without 
apparent colonization. In BALB/c mice, no kidney lesions were 
observed confirming that this strain is more resistant to infection 
(34). Two models of sublethal leptospirosis using adult mice have 
been developed recently (38, 41). Sublethal infection of 7- to 
10-week-old C57BL/6 mice with 106–107 of a bioluminescent 
version of L. interrogans serovar Manilae strain L495 allowed for 
live imaging of infected albino animals. The advantage of using 
live imaging is to allow quantification of live L. interrogans. Mice 
exhibited biphasic disease with a self-resolving hematogenous 
dissemination followed by renal colonization (38). In another 
study, 10-week-old C3H–HeJ mice were inoculated with 106–107 
L. interrogans serovar Copenhageni Fiocruz L1-130. Infection 
led to bloodstream dissemination of L. interrogans, which was 
followed by urinary shedding, body weight loss, hypothermia, 
and colonization of the kidney by live spirochetes 2 weeks after 
infection. In addition, infection triggered inflammation of the 
kidney but not of the liver or the lung. Infection of mice with 
pathogenic Leptospira sp. seems to depend on infectious dose 
and on the mouse genetic background. The sensitivity of the 
techniques used to detect Leptospira sp. in the biological samples 
tested as well as the lack of well-established clinical scores such 
as weight loss and temperature to record disease course may 
account for the inconsistencies reported in the literature. As an 
example, long-term colonization of kidney was also observed in 
BALB/c mice infected with 107 of the bioluminescent version of 
L. interrogans serovar Manilae strain L495 (38).
Mouse and Rat Models of  
Chronic Leptospirosis
A few years after its discovery, more than 100  years ago (10), 
human leptospirosis was associated with the presence of rats and 
mice, identified as asymptomatic renal carriers of a live spiro-
chetal bacterium, named “interrogans” because of its question 
mark’s shape (47). Yet, experimental infection and characteriza-
tion of the disease in these animals is quite recent (48, 49), most 
probably because they are relatively resistant to acute disease 
and therefore were not considered as bona fide models of severe 
human leptospirosis. Nevertheless, knowledge of the biology of 
pathogenic Leptospira sp., the histopathology, and their survival 
in the reservoir host, as well as their transmission to other hosts 
is of utmost importance to better understand and counteract the 
infection in susceptible hosts, like humans.
Two studies characterized renal lesions in brown Wistar rat 
(Rattus norvegicus) experimentally infected through intraperito-
neal route with L. interrogans serovar Copenhageni strain Fiocruz 
L1-130. At a high dose of 108 bacteria, 1 month post-infection, 
all infected rats were asymptomatic, without any loss of weight 
compared to non-infected rats, and presented dense Leptospira 
colonization of renal tubules, without evidence of major inflam-
mation. A total of 2–4  months post-infection around 70% of 
the rats presented renal interstitial nephritis, also observed in 
kidneys of 50% of captured wild rats found positive for Leptospira 
sp. culture (4, 50).
Interestingly, C57BL/6 mice intraperitoneally infected with 
107 of a bioluminescent version of L. interrogans serovar Manilae 
strain L495 (38) showed the same features as previously observed 
in rats (4). Renal colonization remained stable for the lifetime of 
C57BL6/J mice (38). Leptospira sp. persistence may be different 
in rats, depending on the bacteria serovar used for the infection. 
TAbLe 1 | Mice as animal models to study disease caused by pathogenic Leptospira sp.
Mouse 
strain
Genotype Model of disease
Pathogenic Leptospira sp.  
serovar and strain
biological variables
Tissue dissemination 
(technique, dpi)
Major findings Reference
Sex
Age 
(w.o.)
infection 
route/dose
A/J ahl4 mutation Asymptomatic Icterohaemorrhagiae strain Cop F 4–5 IP/103, 106
Kidn  
(IF, dpi 28)
High kidney colonization Santos et al. (34)
CBA pde6b mutation Asymptomatic Icterohaemorrhagiae strain Cop F 6–7 IP/103, 106
Kidn  
(IF, dpi 28)
Inflammatory lesions and  
interstitial nephritis
Santos et al. (34)
BALB/c
Wild type (WT) Asymptomatic
Copenhageni strain Cop ND ND IP/106, 107
Kidn (HP, dpi 28) No signs of disease
Bandeira et al. (35)
CB17 SCID Acute Kidn, Liv, lun (HP, dpi 28) Pulmonary hemorrhage
C57BL/6
WT Asymptomatic Icterohaemorrhagiae strain Cop F 4–5 IP/103, 106
Kidn  
(IF, dpi 28)
Inflammatory lesions and  
interstitial nephritis
Santos et al. (34)
WT Asymptomatic
Copenhageni strain Cop ND ND
IP/103, 106
IP/106, 107
Lun, Kidn  
(HP, dpi 28)
Interstitial nephritis
Bandeira et al. (35)iNOSko Asymptomatic
Rag1-ko Acute
Kidn, Liv, and Lun (HP, 
necropsy dpi 7–10)
Pulmonary hemorrhage
WT
Asymptomatic Copenhageni strain Fiocruz L1–130 
and Manilae strain L495
F 8–10 IP/2 × 108 Liv, Lun, Kidn (qPCR, HP,  
dpi 15, 30, 60, 90, 180)
Renal fibrosis model
Chronic infection
Fanton d’Andon 
et al. (36)Renal colonization
WT
Asymptomatic
Copenhageni strain Fiocruz L1–130 ND 3–4 IP/106
Bl and Kidn  
(qPCR, HP, dpi 14, 90)
Renal fibrosis model
Chronic infection
Ferrer et al. (37)
Renal colonization
Albino
Asymptomatic
Manilae strain L495 (bioluminescent) F 7–10 IP/107, 108
Live imaging  
(dpi 1–142)
Model of biphasic leptospirosis
Chronic infection
Ratet et al. (38)
Renal colonization
C3H
C3H/HeJ (tlr4 
point mutation)
Acute Icterohaemorrhagiae ND 3 ND/~107
Lun, Kidn (HP,  
dpi 14, 20, 180)
Pulmonary hemorrhage
Defects in CD4+ and CD8+ T cells 
correlate with disease progression
Pereira et al. (39)
C3H/HeJ and 
C3H/HeJ/SCID
Sublethal and acute Copenhageni strain RJ16441 ND 3–6 IP/106
Liv, Kidn  
(HP, dpi 3–17)
No lung hemorrhage Nally et al. (40)
C3H/HeJ (tlr4 
point mutation)
Sublethal Copenhageni strain Fiocruz L1-130 F 8–16 IP/106, 107
Uri, BL, Kidn  
(qPCR, HP, dpi 15)
Kidney inflammation
Increased CD4+ effector T cells in 
spleen
Richer et al. (41)
OF1 WT Asymptomatic
L. borgpetersenii  
Ballum strain B3-13S
ND 6–8 IP/108
Kidn, Lun, Liv  
(HP, qPCR, dpi 14, 21, 28)
Renal carriage
No nephritis
Matsui et al. (42)
ND, not described; F, female; w.o., weeks old; IP, intraperitoneal; HP, histopathology; IF, immunofluorescence; BL, blood; Kidn, kidney; Liv, liver; Lun, lungs; Uri, urine; dpi, day post-infection.
Highlighted in gray are the mouse models leading to acute leptospirosis.
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In Wistar rats, L. interrogans serovar Icterohaemorrhagiae per-
sisted for 220 days but L. interrogans serovar Grippotyphosa per-
sisted only 40 days (48) and L. interrogans serovar Copenhageni 
strain Fiocruz L1-130 persisted for 4 months (4). Another study 
using a different strain of the same bacteria serovar showed that 
shedding of L. interrogans serovar Copenhageni strain RJ16441 
in the urine of Sprague-Dawley rats ceased 2–3  months post-
infection (51). Altogether, these data suggest that some rats clear 
Leptospira sp. from the kidney. Nevertheless, the fact that both 
mice and rats shed Leptospira sp. for several months after kidney 
colonization is clearly established. The mechanism leading to the 
sterilization of the kidney is extremely important and remains to 
be investigated.
Another common feature of the rat and mouse models is a 
threshold of infection required to get renal colonization. In rats, 
the dose of 104 bacteria injected intraperitoneally allows for the 
renal colonization of 50% of rats (4). In C57BL/6 mice, the lower 
limit to obtain 100% of renal colonization is 106 bacteria (36, 
38), but this threshold depends on the Leptospira sp. serovar and 
strain, since intraperitoneal injection with 103 L. interrogans sero-
var Copenhageni strain Cop is enough to colonize the kidneys 
of mice (34). Given that the rat can shed up to 107 Leptospira sp. 
per ml of urine (52), we may speculate that high concentration 
of Leptospira sp. in water may associate with higher transmission 
rates. However, the reverse may not necessarily be true.
Renal fibrosis, usually associated with inflammation, is charac-
terized by the pathological accumulation of extracellular matrix 
components, such as collagen, and may compromise the kidney 
function of patients with leptospirosis (53). Fibrosis has also 
been observed in some wild rats (50) and dogs naturally infected 
with L. interrogans (54), and more recently in surviving hamsters 
experimentally infected with Leptospira borgpetersenii serovar 
Ballum (42). Two recent studies found that mild fibrosis occurs 
in kidneys of C57BL/6 mice infected with L. interrogans serovar 
Copenhageni strain Fiocruz L1-130 and serovar Manilae strain 
L495 (36, 37). Both studies found interstitial nephritis in infected 
mice 2 weeks post-infection, decreasing therafter, and sustained 
fibrosis from 2 weeks until 3 or 6 months post-infection. The use 
of antibiotic showed that fibrosis is associated with the presence 
of live bacteria colonizing the kidneys and not antigens (36), 
as previously suggested in  vitro (55). Hence, antibiotic therapy 
initiated in mice 1 day after infection allowed for sterilization of 
kidneys, and fibrosis was not observed 15  days post-infection. 
However, when antibiotic treatment started 3 days post-infection, 
it failed to eradicate Leptospira sp. and fibrosis was still observed, 
although the kidney presented only minimal inflammation (38). 
In mice, it was also shown that the lack of DAF-1, an early regulator 
of complement cascades, aggravates fibrosis induced by infection 
with L. interrogans serovar Copenhageni strain Fiocruz L1-130 
(37). Of note, the bacterial load in the kidneys of hamsters, OF1 
mice (42), and C57BL/6 mice (36, 37) at the chronic phase of 
leptospirosis does not correlate with the extent of fibrosis, sug-
gesting that the initial insult of penetration in the tubule, rather 
than colonization itself or the ensuing inflammation, is important 
for establishment of fibrosis.
Antibiotics administered at the chronic phase, when 
Leptospira sp. are established in the renal tubules, do not easily 
eradicate the pathogen in mice (19, 38) or in humans (2). In 
the chronic stage, Wharthin–Starry staining of rats’ kidneys has 
shown very dense colonization of proximal tubules by L. inter-
rogans (50). Whether Leptospira sp. form biofilm in the tubules, 
as in vitro (56), remains to be demonstrated but it would explain 
the Leptospira sp. resistance to antibiotics in this phase of infec-
tion, in contrast to the acute phase, when antibiotics are effec-
tive if administered early (38). Interestingly, in mice, several 
rounds of the same antibiotic treatment at the chronic phase of 
disease resulted in stepwise reductions of Leptospira sp. (38). 
Together these studies suggest that a small number of bacteria 
reach a low number of renal tubules, where they multiply until 
they completely fill their niche, between 15 days and 3 weeks 
post-infection. Once the niche is filled, the multiplication rate 
would compensate the shedding, potentially explaining the 
observed sustained level of colonization (38). Altogether, these 
data suggest that the establishment of Leptospira sp. in the renal 
proximal tubules is an early event, occurring in the very first 
days post-infection, only when the number of Leptospira sp. is 
high enough to overwhelm the natural blood defenses. These 
data also imply that after the initial entry in a tubule, Leptospira 
sp. do not colonize new tubules, in mice (38). This phenomenon 
could be due to the efficient immunoglobulin (Ig) response (44, 
47) that would control any Leptospira sp. leaving a tubule to 
go back into circulation, before it may infect another nephron. 
Only two studies in the 1980s addressed the mechanism of 
entry of the Leptospira sp. in the tubules, using experimentally 
infected swine with L. interrogans serovar Pomona, or mice. 
They described a biphasic infection with first a hematogenous 
dissemination of Leptospira sp. in the kidney, followed in 
the first 4  days post-infection by the tubular phase, where 
Leptospira sp. cross the tubules till the lumen [reviewed in Ref. 
(52)]. Thereafter, the proximal tubule of the kidney constitutes 
a safe niche where Leptospira sp. are protected from the activity 
of the immune system and do not cause major lesions, aside 
from mild fibrosis, a reminder of the initial tubular insult. The 
reason why Leptospira sp. localizes in the proximal tubules is 
unknown.
Since chronic asymptomatic leptospirosis with prolonged 
shedding of Leptospira sp. in the urine has also been observed 
in humans (9, 57), these results should emphasize the fact that 
prophylactic and antibiotic treatments in humans, like serum 
therapy (58), are important to be administered early after infec-
tion to avoid renal colonization that in the long term may weaken 
the kidney (59).
Although the intraperitoneal route of infection has been 
widely used in leptospirosis animal models, it may not reflect the 
whole process of infection since Leptospira sp. penetrate the body 
through abraded skin or mucosa. A recent study compared infec-
tion with 107 L. interrogans serovar Copenhageni strain Fiocruz 
L1-130 in 7-week-old Wistar rats through mucosal, subcutane-
ous and intraperitoneal routes. Rats infected through all routes 
remained largely asymptomatic. One month post-infection, kid-
neys of all rats infected intraperitoneally were colonized, without 
any sign of interstitial nephritis, although only five out of eight 
rats infected through the mucosal route and only one out of eight 
rats infected subcutaneously were colonized (60), suggesting that 
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natural infection does not systematically lead to renal coloniza-
tion in 7-week-old Wistar rats.
Mouse models of sublethal and chronic infection may allow 
us to better understand leptospirosis and host factors that lead to 
immune evasion, which can result in acute or chronic disease and 
susceptibility or resistance to infection (41).
PROFiLiNG iMMUNe ReSPONSeS  
TO PATHOGeNiC Leptospira USiNG 
MOUSe MODeLS
The wide availability of genetically defined congenic strains of 
mice is currently leading to a new trove of knowledge on the 
engagement of immune system components with pathogenic 
Leptospira sp., which informs our understanding of the pathways 
to, and the markers for, protective immunity (61).
Protective Role of Antibodies against 
Lipopolysaccharide (LPS) and  
Roles of TLR4 and TLR2
The humoral response against pathogenic Leptospira sp., 
described as a “bactericidal substance for the spirochaetae in 
the blood of patients” and its ability to destroy Leptospira sp. 
has been demonstrated since 1916. In those studies, serum from 
immunized horses and goats or from convalescent patients with 
leptospirosis was administered to guinea pigs experimentally 
infected with Leptospira sp. or to leptospirosis patients, respec-
tively (10, 58). The authors drew very robust conclusions about 
their data. Indeed, to test the efficiency of sera to clear Leptospira 
sp. from the blood of infected animals or patients suffering from 
leptospirosis, they injected the blood, with or without Leptospira 
sp., into naïve guinea pigs that subsequently did or did not 
develop leptospirosis (58). More recently, mostly mouse models 
of leptospirosis produced important clues about the immune 
cells and receptors involved in susceptibility to leptospirosis 
(40, 43, 44, 62, 63) (highlighted in Table  2). Not surprisingly, 
B cells appeared to be key players and are important to control 
leptospirosis. Indeed, BALB/c mice chemically depleted of B 
cells were shown to be susceptible to lethal leptospirosis induced 
by L. interrogans serovar Pomona in contrast to untreated WT 
mice (43). This observation was confirmed using C3H/SCID 
mice and μMT mice on a C57BL6/J background, both genetically 
deficient for B cells. These mice also died from acute leptospirosis 
when infected with L. interrogans serovar Copenhageni (40, 44). 
Interestingly, the antibody response to Leptospira sp. has been 
shown to appear quickly after infection (58), as early as 3 days in 
the case of IgM after intraperitoneal infection with L. interrogans 
serovar Copenhageni (43, 44).
It is known that most of the protective antibody response to 
Leptospira sp. infection are directed against the LPS. However, 
Leptospira sp. LPS is different from one serovar to another, which 
undermines serovar cross-protection (68). Definite evidence was 
provided in 1986 with a monoclonal antibody elicited against 
LPS that protected guinea pigs against leptospirosis (69). A more 
recent study confirmed passive immunization of guinea pigs with 
agglutinating monoclonal antibodies against LPS (70). The fact 
that Nude mice, unable to produce T cells, were still able to 
mount a protective immune response suggested that protection 
was T cell independent (64), which was consistent with the fact 
that LPS is the target of the antibodies since this molecule is 
known to mediate T independent responses. This observation 
was confirmed using CD3ko mice, lacking T cells (44). The 
crucial humoral response is mediated by TLR4, a member of the 
toll-like receptor family of innate receptors. Those receptors are 
involved in microbial recognition, through conserved molecular 
patterns, such as LPS, and are involved in the expression of 
antimicrobial peptides, chemokines, cytokines, and molecules 
of costimulation, leading to recruitment of immune cells, which 
culminates in the elimination of the pathogen, and therefore 
protection. Indeed, C3H/HeJ mice, known for decades to be 
resistant to LPS endotoxin shock, were often used as model 
of infection since they are more susceptible to many different 
pathogens (i.e., Borrelia burgdorferi). They were subsequently 
shown to have a mutation in TLR4 (71). Four-week-old C3H/HeJ 
are sensitive to acute leptospirosis upon infection with L. inter-
rogans serovar Icterohaemorraghiae (39). Later on, C3H/HeN 
mice that do not have the point mutation in TLR4 were infected 
in parallel with C3H/HeJ mice, and proven resistant to death, 
providing further evidence that TLR4 is important to control 
leptospirosis (63). One of the mechanisms of susceptibility linked 
to TLR4 has been shown to rely on the early production of IgM 
directed against the LPS, and on the production of IgG relying 
on both TLR4 and TLR2 (44). The leptospiral LPS recognition 
by TLR4 is most probably the major factor influencing the 
susceptibility or resistance to infection and disease progression, 
since the lack of this receptor is enough to confer susceptibility 
to Leptospira sp. infection (44). LPS from L. interrogans is atypical 
and is not recognized by TLR4 in human cells, whereas mice 
that are able to recognize the Leptospira sp. LPS are resistant 
to lethal leptospirosis (72, 73), providing an explanation why 
humans are sensitive to acute leptospirosis. Mice are therefore 
excellent reservoir hosts in the enzootic cycle that maintains this 
pathogen in the environment. It is tempting to speculate that 
TLR4 from hamsters, gerbils, and guinea pig would also not be 
able to recognize the Leptospira sp. LPS. Recently, a study using 
mice showed that TRIF, the adaptor of TLR4 and also TLR3, the 
receptor of viral RNA, has a protective role during leptospirosis 
(74). However, the role of TRIF has not been further studied (74), 
but the results showing decreased humoral defense or higher 
L. interrogans burden in the organs of TRIFko mice suggest 
that the role of TRIF is indeed linked to TLR4. Also, LPS from 
Leptospira sp. is atypically recognized by TLR2, the receptor of 
lipoproteins, and this is not conferred by the lipid A moiety, 
but most probably by a lipopeptide linked to the O antigen (72, 
73), which is still unknown. Hence, intraperitoneal injection of 
purified LPS from L. interrogans serovar Icterohaemorrhagiae 
strain Verdun is able to kill C57BL6/J WT mice but not TLR2ko 
mice, in a model of LPS toxicity leading to liver injury and 
mortality, after sensitization of mice with d-galactosamine and 
IFNγ (72). Whether this atypical TLR2 reactivity of the LPS is 
linked to virulence is unknown.
LipL32, the major outer membrane (OM) lipoprotein of 
Leptospira sp. is recognized by TLR2, and therefore is able to 
TAbLe 2 | Mice as animal models to study innate and adaptive immune responses to Leptospira sp. infection.
Mouse 
strain
Genotype Model of disease
Pathogenic  
Leptospira  
sp. serovar and strain
biological variables
Tissue dissemination 
(technique, dpi)
Major findings Reference
Sex Age (w.o.)
infection  
route/dose
BALB/c
Wild type (WT) Asymptomatic
Pomona and Hardjo M, F ~6 IP/~108 109 BL (dpi 1–30)
B cells are important to control 
Leptospirosis
Adler and Faine (43)
Immunosuppressed Acute
Athymic nude Asymptomatic Pomona L10 and 
Copenhageni L45
ND 5–6 IP/~3 × 108 BL (dpi 2–10) Humoral response crucial to control 
Leptospirosis
Adler and Faine (64)
Immunosuppressed Acute
WT Asymptomatic Copenhageni strain  
Fiocruz L1-130
ND ND IP/2 × 108 Kidn (HP dpi 28) No interstitial nephritis Athanazio  
et al. (46)IL4ko Asymptomatic
WT Asymptomatic
Icterohaemorrhagiae  
strain Cop
F 4–5 IP/106 BL, Kidn (IF dpi 28)
High IgG response Santos  
et al. (34)No kidney lesions
C57BL/6
WT, TNFRko, IFNγko Asymptomatic Copenhageni strain  
Fiocruz L1-130
ND ND IP/2 × 108 Kidn (HP dpi 28) TNFR involved in interstitial nephritis Athanazio  
et al. (46)
WT, CD3ko, TLR2ko Asymptomatic
Copenhageni strain  
Fiocruz L1–130
F 8–10 IP/2 × 108 BL, Kidn (qPCR,  
qRT-PCR dpi 3)
Toll-like receptor 4 (TLR4) and  
TLR2-dependent IgM, IgG, iNOS and 
IFN-γ responses
Chassin et al. (44)TLR4ko; TLR2/4dko; MyD88ko Lethal
μMT; Rag2ko Lethal
CD3ko Asymptomatic
WT Asymptomatic Copenhageni strain  
Fiocruz L1-130
F 8–10 IP/106
Kidn (qPCR, ELISA,  
qRT-PCR dpi 3)
Downregulation of transporters in kidneys Lacroix-Lamande 
et al. (65)TLR2/4dko Sublethal infection NLRP3/TLR2/4 dependent IL1β secretion
WT, TLR2ko; TLR3ko;  
TLR5ko; TLR9ko
Asymptomatic chronic renal 
colonization
Copenhageni strain  
Fiocruz L1–130 and  
Manilae strain L495
F 8–10 IP/106
Liv, Lun, and Kidn  
(qPCR and HP dpi 15)
TLRs, NLRs, T and B-cells are not 
involved in fibrosis
Fanton d’Andon  
et al. (36)
TLR4ko; TLR2/4dko; MyD88ko Sublethal infection
Nod1ko; Nod2ko; Nod1/2dko, 
Casp1ko
Asymptomatic
μMT Sublethal
iNOS participates in fibrosisiNOSko Asymptomatic
CD3ko Asymptomatic
Daf1ko
Lethal chronic renal  
colonization
Copenhageni strain  
Fiocruz L1–130
ND 3–4 IP/106
BL and Kidn  
(qPCR and HP dpi 14 and 90)
Lack of Daf1 enhances nephritis and 
fibrosis
Ferrer et al. (37)
WT Asymptomatic
Copenhageni strain  
Fiocruz L1–130 and  
Manilae strain L495
M 4 IP/5 × 106 BL, Kidn, and Liv  
(qPCR and HP dpi 3)
Pathogenic Leptospira sp.  
infection trigger formation of  
neutrophil extracellular traps
Scharrig et al. (66)
C3H
C3H/HeJ (tlr4 point mutation)
Lethal and sublethal Icterohaemorrhagiae  
strain HAI188
F 3–6
IP/6 × 108
IP/108
Heart, Spl, Kidn, Lun, and Liv 
(qPCR and HP dpi 21)
TLR4 response important to control 
Leptospira sp. infection
Viriyakosol et al. (63)C3H/SCID
C3H/OuJ (functional TLR4) Asymptomatic
C3H/HeJ Lethal and sublethal
Copenhageni strain  
Fiocruz L1-130
ND 3 IP/107
Kidn  
(qPCR and HP dpi 14)
Protective role of NO against  
Leptospira sp.
Pretre et al. (67)
dko, double knockout; ND, not described; F, female; M, male; w.o., weeks old; IP, intraperitoneal; BL, blood; Kidn, kidney; Liv, liver; Lun, lungs; Spl, spleen; HP, histopathology; IF, immunofluorescence; dpi, day post-infection.
Highlighted in blue are the mouse models potentially leading to lethal infection.
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kidney and also by parenchymal cells, and in liver, its production 
is linked to the presence of B cells (44). The beneficial effect of T 
cells, potentially through IFN-γ production, has been shown in 
the lungs and kidneys of C3H/HeJ mice infected with Leptospira 
sp. and depleted in CD4 and CD8 T cells (65) and in CD3ko/
C57BL/6 mice (44).
Nitric oxide (NO) is an antimicrobial compound, produced 
by the inducible nitric oxide synthase (iNOS) in macrophages 
and endothelial cells. Upon infection with Leptospira sp., iNOS 
is expressed 3 days post-infection in kidneys and lungs of mice 
in a TLR2- and TLR4-dependent manner (44). NO is secreted by 
parenchymal cells in kidneys of infected mice (44), and it plays a 
damaging role in nephritis (35) and in renal fibrotic lesions induced 
by Leptospira sp. (36). Experiments conducted with both Syrian 
hamsters and C3H/HeJ mice treated with a specific inhibitor of 
iNOS showed increased mortality and aggravated renal lesions 
upon infection with L. interrogans serovar Copenhageni strain 
Fiocruz L1-130, suggesting that overall NO plays an important 
antimicrobial role against Leptospira sp. (67). Of note, in renal 
lesions and in pulmonary hemorrhage induced by L. interrogans 
serovar Copenhageni, the potential contribution of autoimmune 
response has been ruled out since in both cases the lesions were 
still present in mice without B and T cells (35, 36).
Other than protective responses resulting from the stimula-
tion of both TLR4 and TLR2, it was shown that leptospirosis 
induced a TLR2- and TLR4-independent inflammation, also 
independent from other TLRs. Indeed, in mice deficient for 
MyD88, the adaptor of almost all TLRs except TLR3, the inflam-
mation upon infection with L. interrogans was equivalent to the 
inflammation found in double TLR2/TLR4ko mice (44). The 
receptor responsible for this detrimental inflammation remains 
to be determined.
Role of Neutrophils and Macrophages  
in Leptospirosis
Although neutrophilia is a common feature of human leptospi-
rosis, only few neutrophils were identified in kidneys of mice 
3 days post-infection with L. interrogans (44, 66) and depletion 
of neutrophils did not change the overall course of the disease 
(44, 66, 81), suggesting that neutrophils are not major players in 
murine leptospirosis. However, a recent study in C57BL/6 mice 
showed that L. interrogans serovar Copenhageni strain Fiocruz 
L1-130 triggered, in the dissemination phase, the generation 
of neutrophil extracellular DNA traps (66). NETs from human 
neutrophils killed L. interrogans in  vitro. The depletion of 
neutrophils in mice resulted in increased bacteria 3 days post-
infection in blood and also in kidneys 14 days post-infection, 
although nephritis was not changed, compared to untreated 
infected mice. These results suggest that NETs are an important 
mechanism of host defense occurring early, impairing the 
dissemination of bacteria in the tissues. However, Leptospira 
sp. that manage to settle in the kidneys are obviously able to 
escape this defense (66), suggesting that these bacteria reached 
the kidneys before the onset of NET generation 1–2 days post-
infection. Alternatively, NET escape may be due to a nuclease 
activity found in pathogenic but not in saprophytic Leptospira 
induce inflammation in vitro in proximal kidney cells (72, 75, 
76). However, the relevance for kidney infection is not clear, 
since the lack of TLR2 did not change fibrosis and did not 
reduce inflammation in kidneys of mice 15 days post-infection 
with L. interrogans (36). Fibrosis was also induced only in the 
presence of live bacteria, not in the presence of LipL32 anti-
gens, present after an antibiotic treatment (36). Nevertheless, 
Leptospira sp. antigens from the OM, including the lipoprotein 
LipL32 may be responsible for nephritis observed in other 
animals, as was very elegantly demonstrated in zebrafish larvae 
(77). Posttranslational modifications of LipL32 have recently 
been studied using Leptospira sp. retrieved from urine of rats 
chronically infected with L. interrogans serovar Copenhageni 
strain RJ16441 (78). The authors showed acetylation or tri-
methylation of lysines of LipL32, only in the case of Leptospira 
sp. retrieved from urine but not from Leptospira sp. grown 
in culture. They further showed that the lysine modifications 
lowered the reactivity toward sera from infected patients, sug-
gesting a role in escape from the immune response and helping 
the maintenance of Leptospira sp. in the proximal tubules. Of 
note, the peculiar Leptospira sp. lipid A was also shown to be 
methylated, the methyl group inactivating a phosphate group 
(79), known to be important for human TLR4 recognition of 
lipid A. Whether posttranslational methylation modification 
is a general strategy of Leptospira sp. to escape the immune 
response remains to be investigated.
Protective Host Mediators in Leptospirosis
IL-1β is a pleiotropic cytokine, central in inflammation. Its 
expression is tightly regulated by two signals, the first deriv-
ing from a NF-κB pathway such as TLR or TNF stimulation. 
The second signal activates the inflammasome, a platform of 
proteins leading to activation of Caspase 1, able to cleave the 
pro-IL-1β to mature IL-1β, which can be secreted. Using mouse 
bone marrow-derived macrophages in vitro, it has been shown 
that Leptospira sp. trigger these cells to produce IL-1β, through 
the Nod-like receptor protein 3 (NLRP3) inflammasome (65). 
In mice, LPS and lipoproteins are recognized by TLR4 and 
TLR2, which participate in IL-1β secretion by priming mRNA 
expression of the pro-IL-1β and NLRP3. Leptospira sp. activate 
the NLRP3 inflammasome through a dysregulation of the 
potassium flux (65), due to glycolipoprotein action, known 
to downregulate the potassium pump (80). This has been 
confirmed in  vivo after infection with L. interrogans serovar 
Copenhageni strain Fiocruz L1-130 of TLR2ko or TLR4ko mice. 
It was shown that all the transporters were downregulated and 
the IL1β decreased in both TLR2ko and TLR4ko mice, 3 days 
post-infection (65).
Another inflammatory cytokine, IFN-γ is generally recognized 
as a protective cytokine, able to prime the phagocytic activity 
of macrophages. IFN-γ mRNA expression peaks in hamsters 
between 8 and 18 h post intraperitoneal infection with L. inter-
rogans serovar Icterohaemorraghiae strain Verdun in blood (24). 
Upon infection with L. interrogans serovar Copenhageni strain 
Fiocruz L1-130, IFN-γ mRNA is expressed in the organs of mice 
3  days post-infection through a TLR2- and TLR4-dependent 
pathway (44). IFN-γ has been shown to be produced by T cells in 
10
Gomes-Solecki et al. Animal Models of Leptospirosis
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 58
sp. (66). Unchanged nephritis despite higher bacterial coloniza-
tion is difficult to interpret but reminds us that fibrosis is not 
proportional to the bacterial load (36).
Several in vitro and one in vivo study depleting macrophages 
with silica particles suggest that macrophages can phagocyte 
Leptospira sp., at least when they are opsonized with specific 
Ig (43, 64, 82). This has been recently confirmed in vivo using 
zebrafish (83). Indeed, zebrafish embryos are a powerful model 
to study host–pathogen interactions. They have a functional 
innate immune system close to the mammalian immune system. 
The embryos are transparent and allow tracking of fluorescent 
bacteria. Using Syto-83 dye labeled and unstained L. interrogans 
serovar Copenhageni strain Fiocruz L1-130, the authors showed 
rapid encounter and internalization of Leptospira sp. in phago-
cytes 2 h post intravenous injection and survival of Leptospira sp. 
in these cells until 48 h post-infection (83). Strikingly, the infected 
phagocytes changed morphology and specifically migrated in a 
dorsal part of the embryo, which has never been observed with 
other pathogens, suggesting that phagocytes could help Leptospira 
sp. traffic inside the host (83). Whether this observation could be 
relevant in mammals is unknown.
Human Genetic Polymorphisms 
Associated with Susceptibility to 
Leptospirosis
Human genetic polymorphism studies are very useful to under-
stand the mechanisms involved in immune response to diseases. 
Only a few studies have been performed on polymorphisms in 
innate immune genes known to be associated with infectious 
diseases that could be relevant for leptospirosis (84–86). A study 
on an Argentinian population suggested that polymorphisms on 
both tlr2 and in tlr1 genes may confer enhanced susceptibility to 
severe leptospirosis (86). It has also been suggested that, among 
other factors, polymorphisms in IL-4 and IL-4R (84) and IL-1β, 
IL-12R, and CISH (multiple cytokines inducible SH2-containing 
protein gene) (85) correlated with susceptibility to leptospirosis. 
However, these studies produced discordant results, despite the 
fact that two were performed a few years apart in two distinct 
cohorts of patients from Terceira (84) and São Miguel (85) neigh-
boring islands in the Azores archipelago, Portugal. The role of IL-4 
has been studied in mice, but the resistance of BALB/c/IL-4ko 
mice to the infection with L. interrogans serovar Copenhageni 
strain Fiocruz L1-130 was comparable to WT BALB/c, suggesting 
that IL4 does not play a major role in leptospirosis in these mice 
(46). The association of tlr2 polymorphism with leptospirosis (86) 
was not found in the Terceira Island study (84), which also did 
not find the IL-1β polymorphism found in the São Miguel Island 
(85). Interestingly, the São Miguel study did not find polymor-
phisms in TLR4 associated with susceptibility to leptospirosis 
(85), which is consistent with the finding that the atypical LPS 
from Leptospira sp. does not signal through TLR4 in humans (69, 
70). The small cohorts (around 100) of leptospirosis patients may 
be one of the factors decreasing the significance of these results. 
Thus, larger studies with multifactorial analysis are needed to 
confirm the potential protective roles of cytokines and TLRs in 
human leptospirosis.
A summary of the use of mice as animal models to study 
innate and adaptive immune responses to Leptospira sp. infection 
is provided in Table 2, and a diagram of the immune response to 
Leptospira sp. infection is provided in Figure 1.
viRULeNCe FACTORS OF Leptospira sp. 
ASSeSSeD wiTH ANiMAL MODeLS OF 
LePTOSPiROSiS
To establish whether a gene encoded by a pathogen can contribute 
to its virulence, the classical approach involves genetic inactiva-
tion and study of the outcome of infection with the mutant strain. 
Targeted genetic manipulation of Leptospira sp. is still not achiev-
able on a routine basis; however, random mutagenesis by trans-
poson insertion made it possible to generate mutant strains that 
can be tested in animal models to evaluate the role of the mutated 
gene in virulence. In a limited number of studies, complementa-
tion of the mutant was achieved (87–90) and allowed to fulfill the 
molecular Koch’s postulates (91), since the complementation of 
the mutated non-virulent (NV) strains restored virulence.
This section describes the Leptospira sp. virulence factors 
characterized in studies fulfilling the following criteria: (1) no 
difference in the in vitro growth rate at 30°C between the WT 
and mutant strains; (2) the WT Leptospira sp. strain caused 
death of all the infected individuals (lethal challenge), whereas 
the mutant strain, at equivalent dose, results in the survival of all 
animals. Moreover, we discriminate the bacterial phenotype as V, 
causing death of the host, or NV, which does not kill the host and 
is not found in organs and kidneys (Figure 2). A mutant strain 
is considered NV attenuated when it still colonizes target organs, 
including kidneys. Hamsters, guinea pigs, and gerbils used for 
studying acute leptospirosis will succumb to the infection in a 
period ranging from 5 to 10 days for V strains, whereas they will 
survive with no clinical signs of the infection when NV or attenu-
ated strains are administrated. Some of the studies also included 
a test in rats or mice to check kidney colonization.
As shown in Figure 2 and Tables 3 and 4, around 20 genes 
have been tested for their potential role in virulence in leptospi-
rosis. Half of them have been identified as essential for virulence 
(highlighted in Tables 3 and 4). Two components of the cell wall, 
the endoflagella and LPS, appear to be true virulence factors, since 
mutations in several genes involved in motility or LPS synthesis, 
result in the loss of virulence (Figure 2; Table 3).
endoflagella As a virulence Factor
A mutant of the flagellar subunit FlaA2 (92) resulted in a flagel-
lum more flexible than the WT. This bacterium lost translational 
motility and was not virulent in hamsters. Moreover, 5 days post-
infection, the FlaA2 mutant was not found in organs, suggesting 
that motility is also essential for early dissemination in tissues 
(92). Similarly, an abundant protein exposed at the surface of the 
flagellum filament, called Flagellar coiling protein (Fcp)A was 
recently characterized (88). Mutants in the fcpA gene, either from 
clinical isolates or constructed by allelic exchange, lost the hook 
shape, presented uncoiled flagella, and lost motility (88). This 
mutant also lost its ability to translocate in vitro across polarized 
kidney cells (88), suggesting that the step of active penetration in 
Diagram of immune responses induced by Leptospira sp. infection 
in mice. Known innate responses to Leptospira sp. involve neutrophils, 
macrophages but also B and T cells. Recognition of Leptospira sp. mostly 
occurs through the TLR2 pathway, sensing outer membrane proteins 
(OMPs) such as the lipoprotein LipL32, the major leptospiral OMP and the 
atypical LPS (72), which is also recognized by toll-like receptor 4 (TLR4) in 
mice (73). Protective host responses are depicted in green on the right 
side, whereas potential unfavorable responses are in red, on the left side. 
In mouse B cells, TLR4 stimulation by leptospiral LPS leads to the early 
production of partially protective IgM (44), via the TRIF adaptor (74). TLR2 
and TLR4 responses, through the Myd88 adaptor, also control the 
production of protective IgG (44). In vivo methylation of LipL32 in rat has 
been shown to reduce its recognition by human antiserum (78). In humans, 
leptospiral LPS is not recognized by TLR4 (73), potentially leading to 
disease, as observed with TLR4 mutant mice (39, 44, 63). In mouse T cells, 
Leptospira interrogans signal through the MyD88-dependent activation of 
TLR4 and TLR2 receptors and trigger the production of the protective 
pro-inflammatory cytokine IFN-γ that activates macrophages (44). Both T 
and B cells, by sensing leptospiral components through an unknown 
receptor, are involved in the production of an unfavorable pro-inflammatory 
cytokine response (44). In humans, neutrophils play a slight protective role 
for the host against Leptospira sp. infection due to the production of 
bactericidal neutrophil extracellular traps (NETs) (66). Neutrophils and 
macrophages barely phagocytize non-opsonized Leptospira sp. but 
opsonized Leptospira sp. with specific IgG are readily killed by 
phagocytose (43, 82). Macrophages produce pro-inflammatory cytokines 
leading to a protective inflammatory state by sensing OMPs, including 
LipL32, via TLR2 (72). The atypical leptospiral LPS is also detected by 
TLR2 and CD14, the co-receptor of TLR4 (72). Acting in concert with TLR2 
and TLR4 activation, leptospiral glycoprotein blocks the Na/K-ATPase 
pump that triggers the activation of the Nod-like receptor protein 3 (NLRP3) 
inflammasome and enables the secretion of the pro-inflammatory cytokine 
IL-1β (65). Upon L. interrogans infection, macrophages and other cells also 
produce nitric oxide (NO), which has a positive and a negative effect. NO 
has a protective effect through the action of its antimicrobial role (67) and 
the negative effect is that NO activity favors kidney fibrosis (36) and 
nephritis of infected hosts (35, 67).
FiGURe 1 | Continued
FiGURe 1 | Continued 
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the tubule might require bacterial motility. Moreover, the intra-
peritoneal or conjunctival infection of FcpA mutant strains in 
hamsters did not result in disease or colonization of the kidneys, 
although complementation restored the flagella coiling, transla-
tional motility, and virulence. Mutations on different components 
of the flagellar motor switch, such as FliY (93) and FliM (89), 
resulted in mutant strains that are deficient in motility in soft 
agar plates and were not able to cause disease in guinea pigs or 
hamsters, respectively. Of note, the trans-complementation with 
a WT copy of the fliM gene on the pMaori replicative plasmid 
(105) restored motility and virulence. These results indicate that 
when the flagellar motor is not able to propel the flagella or when 
the bacteria do not have a fully functional flagellum, pathogenic 
Leptospira sp. are impaired in their ability to move, which as a 
consequence impairs the dissemination in host tissues and pre-
vents disease progression.
LPS As a virulence Factor
Several mutant strains in genes annotated as LPS biosynthesis 
genes showed a NV phenotype (Table 2; Figure 2), demonstrating 
that this cell wall component is crucial for virulence. The LPS is 
a complex molecule encoded by a huge locus larger than 100 kb, 
rather conserved among pathogenic Leptospira sp. strains (106). 
LPS is constituted of three parts, the lipid A moiety that anchors 
the LPS in the OM, a conserved core oligosaccharide, and a 
polysaccharide component, the immunogenic O antigen, which 
is highly variable in composition and length. Antigenic diversity 
constitutes the basis of the serological classification of pathogenic 
Leptospira sp. Two mutants in the LPS biosynthesis locus of the 
L. interrogans Manilae strain L495, M895 altered in Lman-1456 
(LA1641) and M1352 altered in Lman-1408 (94) have been 
obtained by random mutagenesis (94). Both of the genes were of 
unknown function and Lman-1408 was specific to the Manilae 
strain. According to electrophoretic profiles after silver staining, 
M895 was truncated in the O antigen but not M1352. Both pre-
sented altered recognition by a polyclonal serum against the WT 
Manilae L495 strain and were NV in the hamster model, even at 
the very high dose of 107 bacteria. Interestingly, it was later shown 
that both mutants M895 and M1352 were also impaired in their 
ability to colonize the kidney of BALB/c mice (107) (Table 3).
Two other mutant strains of L. interrogans serovar Manilae 
L495 have been obtained by random mutagenesis in two 
different genes, both annotated lpxD, coding for LpxD, the 
FiGURe 2 | Leptospira sp. virulence factors identified in animal models of lethal disease. The panel depicts the different factors (in capitals) and genes 
tested for virulence in different animal models (summarized in Tables 3 and 4) and their localization in Leptospira sp. The mutant strains were inoculated via the 
intraperitoneal route, using both lethal and sublethal bacterial doses, in different animal models for acute disease: hamster (blue), guinea pig (purple), and gerbil 
(green). In all cases, the mutant strains were compared with their wild-type counterpart to assess the effect on virulence of the mutated genes. As schematized on 
top of the panel, we discriminate the genes in two groups; the genes not involved in virulence (on the left side of the panel), since the mutant strain killed the host, 
and the virulence genes (right side of the panel) determined since the mutant strain did not cause the death of animal. In this category, we further distinguish the 
non-virulent (NV) mutants that did not colonize target organs and the NV attenuated ones that did. Attenuated mutants are indicated by underlined names. 
Complementation of mutated genes was not always achieved, and the complemented mutants are indicated with a star (*). OM, outer membrane; IM, inner 
membrane; OMP, outer membrane protein.
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N-acyltransferase of lipid A biosynthesis (Table 3). In different 
bacteria, change in temperature upon entry in the host regulates 
the function of LpxD, which modifies the number or length of 
acylated chains in the lipid A. Since LPS is an abundant compo-
nent of the OM, the modified hydrophobicity of the lipid A can 
directly influence the OM fluidity. This mechanism appears to 
be important for the host adaptation to temperature changes, 
and therefore to virulence (108). The mutant strain in the gene 
la0512 (90) annotated lpxD1, was NV in gerbils. Compared to the 
parental strain or to the second mutant lpxD2, still V, the LpxD1 
mutant had altered growth at 37°C, although growth at 30°C was 
not altered. The LpxD1 mutant also had reduced resistance to 
the antimicrobial peptide polymyxin B at 37°C, reflecting altered 
OM integrity. Complementation of the LpxD1 mutant restored 
all altered phenotypes, as well as virulence (90). However, the 
structure of the lipid A from the WT and mutant strains grown 
in vitro at different temperatures were analyzed by Maldi-MS but 
surprisingly it did not show major modifications of the structure 
(90), found identical to the lipid A structures from L. interrogans 
serovar Icterohaemorraghiae strain Verdun and serovar Pomona 
strain L170 (79). These results raised questions about the bio-
chemical function of the Leptospira sp. enzymes annotated as 
LpxD that potentially could acylate components other than lipid 
A. Nevertheless, the LPS of the LpxD1 mutant was not recognized 
by a polyclonal serum against L495, suggesting that the enzyme is 
indeed modifying the LPS structure. Moreover, in L. interrogans 
serovar Copenhageni strain L1-130, able to cause acute disease 
in the guinea pig and asymptomatic chronic renal colonization 
in rats, it has been shown that the O antigen content of the LPS is 
decreased in bacteria retrieved from the liver of moribund guinea 
pigs, compared to the LPS of bacteria retrieved from the kidneys 
of rats. The latter also showed the same electrophoretic profiles 
than the LPS prepared from bacteria grown in EMJH (51). These 
data suggest that the modulated expression of the O antigen 
TAbLe 3 | Animal models to study Leptospira interrogans mutants in motility and LPS biosynthesis genes.
Function
L. interrogans 
serovar and 
strain
Gene/name
biological variables
bacterial 
phenotype
Tissue dissemination 
(technique, dpi)
Reference
Animal Sex
Age 
(w.o.)
infection 
route/dose
Motility
Australis 702
fliM (LIC11836)
Flagellar motor switch protein
Hamster F 6 IP/106, 108 NV (c+) ND (dpi 21) Fontana et al. (89)
Manilae strain 
L495
flaA1 (LIC10787)
Hamster M 4 IP/103, 106 V
Kidn+; Liv+  
(qPCR, dpi 5–7)
Lambert et al. (92)
Flagellar subunit
Manilae strain 
L495
flaA2 (LIC10788)
Hamster M 4 IP/103, 106 NV
Kidn−; Liv−  
(qPCR, dpi 21)
Lambert et al. (92)
Flagellar subunit
Lai strain Lai
fliY (LA2613)
Flagellar motor switch protein
Guinea pig ND 3
IP/6 × 108, 
1.2 × 109, 
3 × 109, 6 × 109
NV ND Liao et al. (93)
Copenhageni 
strain Fiocruz 
LV2756
fcpA
Flagellar coiling protein
Hamster M 3–6
IP/108 NV (c+)
Kidn−; Liv−; Lun−; Spl−; 
Eye−; BL− (qPCR, dpi 21)
Wunder et al. (88)
CJ/108 NV 
Kidn−; Liv−; Lun−; Spl−; 
Eye−; BL− (qPCR, dpi 21)
LPS 
synthesis
Manilae strain 
L495
lpxD1 (LA051)
LPS modification enzyme
Gerbil ND ND IP/104 NV (c+)
Kidn− (qPCR,  
culture, dpi 20)
Eshghi et al. (90)
Manilae strain 
L495
lpxD2 (LA4326)
LPS modification enzyme
Gerbil ND ND IP/104 V
Kidn+  
(qPCR, culture, dpi 20)
Eshghi et al. (90)
Manilae strain 
L495
Lman-1456 (LA1641)
Hamster ND ND
IP/103 NV Kidn− (culture, dpi 21)
Murray et al. (94)
LPS synthesis CJ/106 NV ND
Manilae strain 
L495
Lman-1408 (LA1641)
Hamster ND ND IP/103 NV Kidn− (culture, dpi 21) Murray et al. (94)
LPS synthesis
M, male; F, female; ND, not described; w.o., weeks old; IP, intraperitoneal; CJ, via conjunctiva; NV, non-virulent; V, virulent; c+, complementation restored virulence; BL, blood; Kidn, 
kidney; Liv, liver; Lun, lungs; Spl, spleen; dpi, day post-infection.
The numbers in brackets refer to the corresponding annotated genes in L. interrogans Copenhageni strain Fiocruz L1-130 (LIC), or in L. interrogans Icterohaemorraghiae strain Lai (LA).
Highlighted in light orange are the genes involved in virulence.
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part of the LPS is important for virulence in the acute model of 
infection. These studies showed that Leptospira sp. LPS is crucial 
for virulence although the underlying mechanism remains to 
be understood. Potentially, the decreased O antigen could help 
the bacteria escape early antibody response, shown in mice to 
occur as soon as 3 days post-infection (44). At the chronic phase 
in the rat, the O antigen is fully expressed, possibly protecting 
Leptospira sp. from the IgG response. We could speculate that this 
complete form of LPS could provide bacteria shed in urine with 
some advantage in survival in the environment or in the early 
phase of infection.
LoA22, Mammalian Cell entry (Mce), and 
ColA OMPs Are virulence Factors
The OMP LoA22, whose function is still unknown, is one of the few 
OM candidate protein (Table 3; Figure 2) shown to be a virulence 
factor (87). LoA22 was found to be the most upregulated OMP 
in the liver of moribund guinea pigs infected with L. interrogans 
serovar Copenhageni (109). In hamster, the loA22 mutant of the 
L. interrogans serovar Lai was NV, and the complementation 
restored the virulence. Interestingly, the same mutant was found 
only attenuated in guinea pigs, since it did not kill the animals 
and was not found in the liver but still colonized the kidneys (87). 
These results suggest that LoA22 displays an important role at the 
acute phase of the infection during multiplication in blood or dis-
semination in tissues, but may not be a key player in permeation 
of the tubules.
Other OMPs that might be considered as involved in invasion 
of Leptospira sp. are the Mce protein (98), which has homologs 
in other pathogenic bacteria, and the collagenase A protein ColA 
(97), encoding for a protein involved also in host–pathogen 
interactions during invasion and transmission. Both mutants for 
Mce and ColA proteins are attenuated.
LipL32, LipL41, and Ligb OMPs  
Are Not virulence Factors
All the other OM components tested were not involved in 
virulence (Table  4; Figure  2). Particularly striking is the case 
of LipL32, which is the most abundant lipoprotein of the 
OM and is highly immunogenic, and also expressed during 
acute infection of guinea pig (109), but whose expression is 
downregulated in the blood of OF1 mice and hamsters (110). 
Knockdown of LipL32 did not abrogate virulence of the strains 
tested in the acute and the chronic model of the disease, leading 
to death of the hamsters and kidney colonization of rats in the 
same extent of the WT strain (95). Moreover, this mutant was 
TAbLe 4 | Animal models to study Leptospira interrogans mutants in outer membrane proteins (OMPs) genes and other factors.
Function
L. interrogans 
serovar and strain
Gene/name
biological variables
bacterial 
phenotype
Tissue dissemination 
(technique, dpi)
Reference
Animal Sex
Age 
(w.o.)
infection  
route/dose
OMPs
Manilae strain L495
lipL32 (LIC11352)  
OMP
Hamster
ND ND IP/103 V
Kidn+; Lun+; Liv+  
(HP, dpi 7–14)
Murray  
et al. (95)ND ND CJ/10
6 V ND
Wistar rat ND 6 IP/108 V Kidn+ (HP, dpi 15)
Manilae strain L495 lipL41 (LA0615)
OMP
Hamster M/F 4–6 IP/103, 104 V Kidn+ (culture, dpi 21) King  
et al. (96)Pomona strain LT993
Lai strain Lai 56601
loa22 (LA0222)
OmpA-like protein
Hamster M 6–8 IP/5 × 107, 108 NV (c+) ND
Ristow  
et al. (87)Guinea pig M 2–3 IP/2 × 108, 4 × 108 NV (c
+)
Kidn+; Liv− (culture, dpi 21)
A
Lai strain Lai 56601
colA (LA0872)
Hamster M ND IP/106
NV (c+) Kidn+; Lun+; Liv+; Uri+; BL+ 
(CFU, dpi 14)
Kassegne  
et al. (97)Collagenase A
strain Lai
mce
Hamster M 4
IP/105, 106, 107, 
108, 109
NV (c+)
Uri+ (CFU, dpi 14) Zhang  
et al. (98)
Mammalian  
cell entry protein
A
Copenhageni strain 
Fiocruz L1-130
ligB
Hamster M 5–8 IP/10, 102,104 106 V Kidn+ Croda  
et al. (99)Wistar rat ND 4–5 IP/108 V Kidn+ (culture, dpi 9)
Other 
factors
Manilae strain L495
LIC12327
Adenylate/guanylate 
cyclase
Hamster F 4 IP/106 NV
A
BL+; Kidn+; Liv+  
(qPCR, dpi 4)
Lourdault  
et al. (100)
Manilae strain L495 LB139 Hamster ND ND
IP/106 NV (c+)
BL−; Kidn−; Liv−  
(qPCR and IF dpi 5 and 25) Eshghi  
et al. (101)
CJ/107 NV (c+) ND
Manilae strain L495
htpG (LB058)
Hamster M/F 4–6 IP/103, 105, 107
NV (c+)
Kidn+; Lun+; Liv+  
(qPCR, dpi 5)
King  
et al. (102)
High-temperature 
protein G
A
Manilae strain L495 lruA (LIC11003) Hamster M 4 IP/103
NV
Kidn+ (qPCR, dpi 21) Zhang  
et al. (103)A
Manilae strain L495
Pomona strain LT993
katE (LA1859; 
LIC12032) Hamster M 4 IP/106
NV (L495) ND (dpi 21) Eshghi  
et al. (104)
Catalase NV (LT993) ND (dpi21)
M, male; F, female; ND, not described; w.o., weeks old; IP, intraperitoneal; CJ, via conjunctiva; NV, non-virulent; V, virulent; NV A, attenuated or partially virulent; c+, complementation 
restored virulence; BL, blood; Kidn, kidney; Liv, liver; Lun, lungs; Uri, urine; CFU: colony forming units; HP, histopathology; IF, immunofluorescence; dpi, day post-infection.
The numbers in brackets refer to the corresponding annotated genes in L. interrogans Copenhageni strain Fiocruz L1-130 (LIC), or in L. interrogans Icterohaemorraghiae strain Lai (LA).
Highlighted in light orange are the genes involved in virulence and in light yellow the attenuated mutant strains, non virulent but still colonizing the kidneys.
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still V when administered through the conjunctiva, showing 
that Lip32 is not necessary in the first steps of the infectious 
process of penetration through the mucosa (95). It is important 
to note that absence of LipL32 has a deep impact on the cell, 
with 46 genes modulated, as shown by microarray analysis (95), 
although LipL32 does not affect the virulence process. Likewise, 
the third most abundant OM lipoprotein LipL41 is not neces-
sary for virulence of Leptospira sp. in the acute model of the 
disease, since all the animals infected with the mutant strain 
succumbed to the infection (96). These results, both from LipL41 
and LipL32, suggest either that these lipoproteins, of unknown 
function, may be important for the survival of Leptospira sp. 
in the environment or that the numerous lipoproteins encoded 
in the Leptospira sp. genome could have redundant functions, 
which could allow bacteria mutated in a single lipoprotein gene 
to retain virulence. Notably, a targeted mutant of L. interrogans 
serovar Copenhageni strain Fiocruz L1-130 in the protein LigB, 
considered to be involved in Leptospira sp. adhesion to the host 
and upregulated 24  h post-infection in  vivo in blood of both 
OF1 mice and hamsters (110), retained its virulence in both 
models of acute and chronic disease (99) (Table 4).
Other virulence Factors
The catalase KatE (104) is another factor linked with loss of viru-
lence, which could be involved in escape of bactericidal activity 
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from neutrophils and macrophages due to detoxification of ROS 
produced by phagocytes. This hypothesis is supported by the fact 
that KatE is located in the periplasmic space of Leptospira sp. cell 
wall where it can participate in ROS resistance. Mutants of the 
chaperone HtpG (102), which is related to virulence in other bac-
terial species and of the protein LruA, a 28 kDa surface-exposed 
lipoprotein that might interact with the serum apolipoprotein A1 
(103) lead to an attenuated phenotype in the hamster model of 
acute infection.
Also, a putative regulatory locus of L. interrogans Manilae 
L495 (lb139), important for multiple gene regulation, including 
motility genes has been recently shown to be a virulence factor. 
Indeed, the lb139 insertion mutant did not kill hamsters, nor did 
it colonize the organs (101).
A high-throughput method has been developed to screen for 
new virulence factors in L. interrogans serovar Manilae strain 
L495. The technique consists in injecting in the hamster or in the 
BALB/c model of renal colonization, a pool of mutants obtained 
by random mutagenesis. Then, presence of each mutant is tested 
by specific PCR, in the pool of Leptospira sp. retrieved in culture 
from the kidneys of moribund animals, compared to the pool of 
mutants grown in culture. The mutants not found in organs are 
assumed to be NV (107). Recently, an improved version of this 
technique, allowing for direct quantification of mutants in organs 
and blood, and therefore able to assess their relative fitness, has 
been performed in hamsters. A new virulence factor, an ade-
nylate/guanylate cyclase gene, has been identified. This mutant 
was attenuated when tested individually in hamsters (100). 
Interestingly, a soluble adenylate cyclase was previously identified 
as a putative virulence factor using comparative sequencing of a V 
strain of L. interrogans serovar Lai strain 56601 versus an isogenic 
culture derivative strain. This protein was shown in  vivo to be 
highly upregulated in the hamster model compared to the EMJH 
culture, and in  vitro to elevate the intracellular cyclic AMP in 
macrophages (111), therefore potentially reducing the host innate 
TNF response, as previously shown in Mycobacteria-infected 
macrophages (112).
Another recent study using RNA-Seq compared the transcrip-
tome of V L. interrogans serovar Copenhageni grown in  vitro 
in EMJH, to Leptospira sp. cultivated in  vivo within a dialysis 
chamber implanted in the peritoneal cavity (DMC) of Sprague-
Dawley rats (113), mimicking the host adapted state. 10  days 
post inoculation, motile Leptospira sp. harvested in exponential 
growth were used to prepare RNAs. Other than a core of genes 
identically regulated between the two conditions, the authors 
found 166 genes differentially expressed, most of them being spe-
cific of the pathogenic but not the saprophytic strain (113). The 
analysis of the upregulated genes, including a comparison with 
other serovars, provides a comprehensive picture of the genes 
important in the host–pathogen interactions. Some genes already 
known as virulence factors, such as collagenase A, were expressed 
50 times more in DMC than in vitro. Also found in these studies 
were lipoproteins, hemolysins, and flagellar components, but 
most of them are unknown genes that remain to be studied (113).
A summary of the virulence factors of leptospirosis is pre-
sented in Figure 2.
CONCLUSiON AND FUTURe STUDieS
Animal models, such as guinea pigs, gerbils, and in particular 
hamsters, have been instrumental to understand the patho-
physiology of lethal leptospirosis, as well as to get insight into 
the Leptospira sp. genes involved in virulence. Using these animal 
models, high-throughput methods, relatively easy to perform, 
spare animal use and can be applied each time a new random 
mutagenesis (99, 114, 115) is performed and might facilitate the 
discovery of new virulence factors of pathogenic Leptospira sp. 
These models have also been very important to test vaccines, 
which was not the focus of the present review. Vaccines for lepto-
spirosis have been recently reviewed by Adler (116).
The overlooked mouse model has recently proved its useful-
ness to provide insight both in sublethal and chronic leptospi-
rosis, in particular the host immune mechanisms that control 
pathogenic Leptospira sp., thus unlocking an avenue of research 
into the immunological mechanisms of susceptibility or resist-
ance to Leptospira sp. infection. Moreover, these versatile murine 
models are appropriate to test new vaccine candidates and drugs 
to treat leptospirosis. In the near future, the availability of CrispR/
Cas 9 technology should provide new tools to design both new 
deficient mice and targeted mutants of Leptospira sp. to study the 
contribution of unique genes in host–pathogen interaction stud-
ies. The new genetic tools available should also help shift research 
from the current descriptive forms to a more complex mecha-
nistic evaluation of the pathophysiology induced by pathogenic 
Leptospira sp. with the goal of finding the function of specific 
genes. Indeed, transgenic mice models, devoid of certain genes 
or cell subsets that can further be studied in different compart-
ments using the Cre/Lox system, are unique means to understand 
the crucial question of how Leptospira sp. overcome their hosts’ 
immune responses.
Alternative, non-traditional models could also contribute to 
the understanding of chronic infection. Natural outbred strains 
of mice (Mus musculus, Swiss Webster) can be used to study how 
pathogenic Leptospira sp. establish effective infection in reservoir 
hosts without causing disease. Natural hosts of human pathogens 
such as Leptospira sp. develop tolerance to the pathogen and are 
usually asymptomatic when infected, which is the opposite to an 
immune response developed by the “accidental” host (human) 
that succumbs to the pathogenic effect of the agent. These non-
traditional animal models could be used in comparative studies 
with strains of mice engineered to be susceptible to Leptospira sp. 
dissemination. In the “One Health” context, research on resist-
ance and tolerance in reservoir hosts is required for development 
of Public Health measures targeting natural reservoirs and for 
understanding the mechanisms of human leptospirosis and other 
infections.
Human leptospirosis studies are mostly epidemiologic, using 
blood or urine as biological samples, and can only provide a 
limited amount of information about mechanisms of host– 
pathogen interaction. Long-awaited human polymorphisms 
studies have not provided clear answers about innate immune 
genes involved in protection against leptospirosis. Therefore, not-
withstanding ethical concerns about experimentation in humans 
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and animals, increased regulations, and justified restrictions 
about animal use in research, it is extremely important to keep 
developing and using animal models of leptospirosis to further 
our understanding of the disease as well as to identify vaccine 
candidates, therapeutics, and diagnostic assays. New vaccines 
and immuno- or other therapies to prevent rapid progression 
of Leptospira sp. through tissues and colonization of the kidney 
could help prevent severe cases of the disease and save lives. We 
may think that the clinical picture of leptospirosis is rather well 
known, but some unexpected findings may challenge our current 
knowledge. For example, Leptospira sp. were found in lungs of 
asymptomatic wild rats carrying the spirochete in their kidneys, 
adhering to the ciliated surface of the bronchi (117). In addition 
to the intraperitoneal route of infection, necessary to precisely 
determine infectious dose, more physiological routes of infection, 
such as the conjunctival, transdermal, and other mucosal routes 
that have recently been studied in rats (60) and hamsters (27), 
should be investigated in different hosts, including mice, gerbils, 
and guinea pigs. Using a natural route of infection may be how we 
could develop a long-awaited model for neuroleptospirosis (118). 
In addition, disease progression might be different if Leptospira 
sp. is deposited in the peritoneum or if it is deposited in skin 
or mucosal surfaces and expected to waddle through the natural 
barriers including skin, extracellular matrix, and the immune 
system before it reaches target organs.
As an alternative to mammal use, the development of the 
Zebrafish model of leptospirosis (77, 83) should in the future 
also help with innate immunity studies. Indeed, the NF-κB and 
Interferon signaling pathways are conserved through evolution, 
and the generation of genetic mutants in Zebrafish is amenable 
(119). Likewise, the development of a Caenorhabditis elegans 
model, that is well established for characterization of molecular 
mechanisms involved in pathogen activation of innate immune 
pathways, as well as pathological mechanisms, would be wel-
comed to study leptospirosis since the genome of this worm is 
reduced and the genetic tools are available (120). However, it 
is not known yet whether Leptospira sp. are pathogenic for this 
nematode, like are other human or zoonotic pathogens such as 
Coxiella, Salmonella, or Pseudomonas sp.
Leptospirosis is a zoonosis, and humans are just one among 
many other vertebrates to be affected by the disease (3). 
Epidemiologic data show that less than 7% of people infected with 
pathogenic Leptospira sp. die from severe forms of leptospirosis 
(3, 121). The current view that humans mostly suffer from acute 
severe disease is outdated and has recently been questioned 
given that clinical manifestations of human disease recapitulate 
all the different clinical profiles and stages found in animals. It 
ranges from asymptomatic to lethal, encompassing sublethal 
as well as chronic forms. Indeed, chronic renal infection that 
occurs in endemic areas of leptospirosis and asymptomatic 
disease, revealed by seropositive serum against Leptospira sp., 
has recently been shown to favor chronic kidney disease (3, 9, 
59). Interestingly, all these clinical forms can be studied using the 
animal models presented in this review. These data suggest that 
the dichotomy between acute and chronic diseases may be a man-
made artifact and that the classification of leptospirosis according 
to the symptoms may not represent the continuum of a biphasic 
disease, with blood dissemination and seeding of target organs 
with Leptospira sp., which may be severe enough to impair organ 
function and cause death, or depending on the capability of the 
host immune response to control Leptospira sp. dissemination, 
the disease can be mild allowing for natural recovery and kidney 
colonization.
Leptospirosis is a neglected disease with a limited number 
of groups working on it. Compared to B. burgdorferi, another 
spirochete that causes Lyme disease, we still lack a lot of useful 
tools, such as GFP or RFP fluorescent Leptospira, sp. allowing 
for efficient imaging in cells and tracking of bacteria in the host. 
Hopefully, recombinant labeled strains will be constructed, poten-
tially using the replicative plasmid pMaori, adapted to pathogenic 
Leptospira sp. (105), or CrispR/Cas 9 technology. Although not 
allowing sensitive imaging in organs, bioluminescent strains have 
been developed and may also give some clues about the kinet-
ics and localization of Leptospira sp. in different hosts, as well 
as horizontal or vertical routes of transmission of Leptospira sp. 
within hosts, and in the environment (38).
An important topic that until now has been overlooked 
is the species-specificity adaptation of Leptospira sp. to 
their hosts. We know that some Leptospira sp. serovars are 
more commonly associated with particular hosts, such as 
Ballum with mice, Canicola with dogs, Hardjo with cattle, or 
Icterohaemorrhagiae with rats (122, 123). Lately, sequencing of 
hundreds of leptospiral genomes highlighted specific features 
of pathogenic strains (123, 124), but the basis of the host pref-
erences of Leptospira sp. is unknown. Immune factors, such 
as TLR4 and TLR2, contribute to the resistance of the host, 
and most probably shape the nature of the pathogen interac-
tion with a particular species. On the other hand, recent work 
showed that the LPS of pathogenic and intermediate Leptospira 
sp. were different (125). Therefore, future structure–function 
and expression studies of TLRs and NLRs from different 
animals toward molecules from different serovars should 
give interesting clues about the sensitivity of a given species. 
Hopefully, it would explain the leptospirosis symptoms, and 
target organs that may vary from one host to another, such as 
the ocular manifestation in horses, placenta infection in cattle, 
or renal insufficiency in dogs, for example.
Summary
In addition to other animal models, congenic and transgenic 
mouse models of leptospirosis offer a myriad of possibilities 
to advance knowledge of host–pathogen interactions especially 
as it concerns the study of early innate and adaptive immune 
responses to pathogenic Leptospira sp. Mice can be used for 
profiling immune responses to dose-dependent sublethal, 
lethal, and chronic leptospirosis, which could inform under-
standing of the natural disease progression in longitudinal 
studies. From an applied research standpoint, mice are well-
accepted experimental models that can be readily adapted 
to higher throughput testing of either vaccine candidates or 
therapeutic options.
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